Corcept Therapeutics Incorporated (LON:0I3Q)

Corcept Therapeutics Revenue

In the year 2024, Corcept Therapeutics had annual revenue of $675.04M USD with 39.94% growth. Corcept Therapeutics had revenue of $181.89M in the quarter ending December 31, 2024, with 34.33% growth.

• Revenue: $675.04M
• Revenue Growth: +39.94%
• P/S Ratio: 10.37
• Revenue / Employee: $1.35M
• Employees: 500
• Market Cap: 5.59B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	675.04M	192.67M	39.94%
Dec 31, 2023	482.38M	80.52M	20.04%
Dec 31, 2022	401.86M	35.88M	9.80%
Dec 31, 2021	365.98M	12.10M	3.42%
Dec 31, 2020	353.87M	47.39M	15.46%